DEA Puts Narcolepsy Pill Orzeyful in Schedule IV as Takeda Launches It in U.S. at $16,500 per Bottle
Takeda's narcolepsy pill Orzeyful became available by prescription in the United States on Nov. 12, the same day a Drug Enforcement Administration rule placing its active ingredient, oveporexton, in Schedule IV took effect. The DEA issued the change as …